News brexit Intellectual Property Publications
Wednesday February 17th, 2021
Sorry, this entry is only available in Polish.
Sorry, this entry is only available in Polish.
It is our privilege to share that, yet another year in a row, SK&S and the firm’s lawyers have been…
In Poland, as in other EU member states, comparative advertising is permitted, subject to the rules provided under the Unfair…
We are pleased to invite you to read the article: “Financial Penalties Upon Influencers for Lack of Cooperation With the…
We are pleased to inform that the “International Comparative Legal Guide to: Pharmaceutical Advertising 2018 – 15th Edition” has been…
We are proud to announce that in this year’s edition of The Legal 500 we have been recommended in 13…
We are pleased to announce that The Legal 500: Patent Litigation Comparative Guide has been published by Legal500. The Polish…
We are pleased to announce that the “Chambers Patent Litigation 2022 Global Practice Guide” has been published by Chambers and…
Sołtysiński Kawecki & Szlęzak has been recognised by the IP Stars 2023 ranking and is among the best Polish law…
We are pleased to announce that SK&S has been ranked in the gold category in the ranking of The World’s…
As of 1 January 2023, the rules governing the advertising of medical devices, systems, and treatment kits in Poland will…
We are proud to announce that Sołtysiński Kawecki & Szlęzak has been ranked as a Top Tier firm among Polish…
We are pleased to announce that the “International Comparative Legal Guide to: Pharmaceutical Advertising 2020 – 17th Edition” has been…
We are pleased to announce that the law firm SK&S and individual experts have once again been singled out by…
We are pleased to announce that SK&S has been ranked in the gold category in the ranking of The World’s…
We are pleased to announce that our IP team won a Gold Laurel in the ranking of the IAM Patent…